Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
179.70B
Market cap179.70B
Price-Earnings ratio
9.87
Price-Earnings ratio9.87
Dividend yield
3.04%
Dividend yield3.04%
Average volume
9.98M
Average volume9.98M
High today
$40.63
High today$40.63
Low today
$39.96
Low today$39.96
Open price
$40.33
Open price$40.33
Volume
12.21M
Volume12.21M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Investing.com 2h
Novo Nordisk shares jump 6% after lifting 2026 outlook on obesity-drug demand - Investing.com

...

Novo Nordisk shares jump 6% after lifting 2026 outlook on obesity-drug demand - Investing.com
The Wall Street Journal 4h
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues

Wegovy pills in a manufacturing machine. Analysts had expected Novo to raise its guidance on the uptake of the pill. Novo Nordisk Novo Nordisk NOVO.B -0.02 %de...

Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
The Motley Fool 3d
Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?

Shares of Novo Nordisk (NVO +2.20%) have declined roughly 70% from their 2024 high. The stock is now below its level in mid-2021, when it first introduced the W...

Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?

Analyst ratings

50%

of 6 ratings
Buy
16.7%
Hold
50%
Sell
33.3%

More NVO News

Simply Wall St 5d
Novo Nordisk Could Be 62% Undervalued On GLP 1 Growth Expectations

Advertisement Recent Share Performance and Business Profile Novo Nordisk (NYSE:NVO) has been trading around US$39.14 per share, with the price moving higher o...

24/7 Wall St. 6d
Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases

Investing Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases Eli Lilly just posted a quarter that left...

Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases
TipRanks 7d
Novo Nordisk Advances Mim8 Trial in Rare Haemophilia A, Expanding Its Specialty Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study “A Multinational, Open-label Study to Investigate Efficacy and Safety of Dene...

Investor's Business Daily 7d
Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test

Technology Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test Licensing Eli Lilly's (LLY) next-generation weight-loss drug, retatrutide, tr...

Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.